The industry’s Racing Medication and Testing Consortium (RMTC) will recommend that the anabolic steroid stanozolol, currently allowed for therapeutic use up to 30 days prior to racing, be eliminated from the list of substances with a recommended threshold level.

The change was one of several actions taken by the RMTC board of directors during its regular meeting Sept. 17 in Denver, Colo.

The recommendation will be presented to the Association of Racing Commissioners International. That group makes model rule recommendations that it encourages state regulator members to adopt.

The stanozolol recommendation would mean the anabolic steroids would not be permitted at any concentration in a horse’s system on race day. The previous threshold allowed stanozolol to be administered up to about 30 days prior to racing